Antidiabetic effect of Dodonaea viscosa aerial parts in high fat diet and low dose streptozotocin-induced type 2 diabetic rats: A mechanistic approach

Pharmaceutical Biology

Volumn 48, Issue 10, 2010, Pages 1137-1148

  Veerapur, V P ^a   Prabhakar, K R ^a   Kandadi, M R ^a   Srinivasan, K K ^a   Unnikrishnan, M K ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Dodonaea viscosa; Glucose uptake; High fat diet; PPAR ; PTB 1B; STZ

Indexed keywords

ALCOHOL; ANTIDIABETIC AGENT; ANTIOXIDANT; DODONAEA VISCOSA EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; PROTEIN TYROSINE PHOSPHATASE 1B; QUERCETIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DODONAEA VISCOSA; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG DETERMINATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SCREENING; FRACTIONATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; SAPINDACEAE; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; INSULIN; LIPID METABOLISM; LIPID PEROXIDATION; MALE; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; QUERCETIN; RATS; RATS, WISTAR; SAPINDACEAE; STREPTOZOCIN;

DODONAEA VISCOSA; RATTUS; SAPINDACEAE;

EID: 77954984111     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880200903527736     Document Type: Article

References (31)

1. Aswal BS, Bhakuni DS, Goel AK, Kar K, Mehrotra BN (1984): Screening of Indian plants for biological activity- Part XI. Ind J Exp Biol 22: 487-504.
2. Basciano H, Federico L, Adeli K (2005): Fructose, insulin resistance and metabolic dyslipidemia. Nutr Metab 2: 1-5.
3. Berger J, Bailey P (1996): Thiazolidinediones produce conformational changes in peroxisome proliferator activated receptor gamma: Binding and activation correlate with antidiabetic actions in db/ db mice. Endocrinology 137: 4189-4195.
4. Friedewald WT, Levy RI, Fredrickson DS (1972): Estimation of lowdensity lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 18: 499-501.
5. Gelvan D, Saltman P (1990): Different cellular targets of Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbiturate acid assay. Biochim Biophys Acta 1035: 353-360.
6. Getie M, Gebre-Mariam T, Rietz R, Hohne C, Huschka C, Schmidtke M, Abate A, Neubert RH (2003): Evaluation of the anti-microbial and anti-inflammatory activities of the medicinal plants Dodonaea viscosa, Rumex nervosus and Rumex abyssinicus. Fitoterapia 74: 139-143.
7. Ghosh R, Sharatchandra KH, Rita S, Thokchom IS (2004): Hypoglycemic activity of Ficus hispida (bark) in normal and diabetic rats. Ind J Pharmacol 36: 222-225.
8. Hevener A, Reichart D, Janez A, Olefsky J (2002): Female rats do not exhibit free fatty acid-induced insulin resistance. Diabetes 51: 1907-1912.
9. Ji-Hu Z, Chung TDY, Oldenburg KR (1999): A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67-73.
10. Joshi SD, Badiger AM, Ashok K, Veerapur VP, Shastry CS (2003): Wound healing activity of Dodonaea viscosa leaves. Ind Drugs 40: 549-552.
11. Kirtikar KR, Basu BD (1993): Indian Medicinal Plants, second edition. Vol.I. Dehradun, India, International Book Publisher.
12. Korcsmaros T, Szalay MS, Böde C, Kovács IA, Csermely P (2007): How to design multi-target drugs: Target search options in cellular networks. Expert Opinion Drug Discov 2: 1-10.
13. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H (1996): Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, GLUT 4, and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 98: 43-49.
14. Lowry OH, Rosenhrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
15. Mahesh T, Venugopal PM (2004): Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res 18: 123-127.
16. Markham KR (1982): Techniques of Flavonoid Identification. London, Academic Press.
17. Perry LM, Metzger J (1980): Medicinal Plants of East Southeast Asia. Cambridge, MA and London, MIT Press.
18. Petersen KF, Krssak M, Inzucchi S, Cline GW, Dufour S, Shulman GI (2000): Mechanism of troglitazone action in type 2 diabetes. Diabetes 49: 827-831.
19. Prabhakar KR, Veerapur VP, Parihar KV, Priyadarsini KI, RAO BS, Unnikrishnan MK (2006): Evaluation and optimization of radioprotective activity of Coronopus didymus Linn. in gammairradiated mice. Int J Rad Biol 82: 525-536.
20. Rajas A, Cruz S, Ponce-Monter H, Mata R (1996): Smooth muscle relaxing compounds from Dodonaea viscosa. Planta Med 62: 154-159.
21. Rajasekar P, Kaviarasan S, Anuradha CV (2005): l-Carnitine administration prevents oxidative stress in high fructose-fed insulin resistant rats. Diabetologica Croatica 34: 21-28.
22. Shafrir E (2003): Diabetes in animals: Contribution to the understanding of diabetes by study of its etiopathology in animal models, in: Porte D, Sherwin RS, Baron A, ed., Diabetes Mellitus. New York, McGraw-Hill, 231-255.
23. Shimizu S, Ugi S, Maegawa H, Egawa K, Nishio Y, Yoshizaki T, Shi K, Nagai Y, Morino K, Nemoto K (2003): Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 278: 43095-43101.
24. Srinivasan K, Patole PS, Kaul CL, Ramarao P (2004): Reversal of glucose intolerance by pioglitazone in high-fat diet fed rats. Methods Find Exp Clin Pharmacol 26: 327-333.
25. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P (2005): Combination of high-fat diet-fed and low-dose streptozotocintreated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 52: 313-320.
26. Taylor SI (1999): Deconstructing type 2 diabetes. Cell 97: 9-12.
27. Veerapur VP, Badiger AM, Joshi SD, Nayak VP, Shastry CS (2004): Antiulcerogenic activity of various extracts of Dodonaea viscosa (L) Jacq. Leaves. Ind J Pharm Sci 66: 407-411.
28. Veerapur VP, Prabhakar KR, Parihar VK, Bansal P, Kandadi MR, Srinivasan KK, Priyadarsini KI, Unnikrishnan MK (2009): Antidiabetic, hypolipidaemic and antioxidant activity of Dodonaea viscosa aerial parts in streptozotocin-induced diabetic rats. J Herb Pharmacother, in press.
29. Vessal M, Hemmati M, Vasei M (2003): Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 135C: 357-364.
30. Zang ZY, Lee SY (2003): PTP-1B inhibitors as potential therapeutics in treatment of type 2 diabetes. Exp Opin Investig Drugs 12: 223-233.
31. Zimmermann GR, Lehár J, Keith CT (2007): Multi-target therapeutics: When the whole is greater than the sum of the parts. Drug Discov Today 12: 34-42.